MedTrace Logo

QStat Cartridge in Obstetric Patients

NCT06255496 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 296

Last updated 2025-11-14

No results posted yet for this study

Summary

This study will assess the performance of the Quantra System with the QStat Cartridge versus standard of care coagulation testing in pregnant women at risk of bleeding at delivery.

Conditions

  • Blood Loss Massive
  • Post Partum Hemorrhage

Interventions

DIAGNOSTIC_TEST

Quantra Hemostasis Analyzer with the QStat Cartridge

Diagnostic device to monitor coagulation properties of a whole blood sample at the point-of-care.

Sponsors & Collaborators

  • HemoSonics LLC

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-09
Primary Completion
2025-08-15
Completion
2025-10-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06255496 on ClinicalTrials.gov